In this episode, we shift to the topic of exosomes in our chat with Jim West, CEO of Clara Biotech. Jim shares his perspective on the use of exosomes in diagnostics and therapeutics and where he sees this technology headed. Join us for an engaging conversation! Experience the Speaking of Mol Bio podcast in its extended video format for a more immersive journey, while also ensuring accessibility with downloadable transcripts for each episode. Watch now at www.thermofisher.com/podcast-video
It’s been 40 years since extracellular vesicles, or exosomes, were first connected to the way cells communicate and transfer information. Since then, researchers have studied what part they play in the normal physiology of a cell. There has also been an expanding amount of work in the role that exosomes can play in therapeutics and diagnostics of a wide range of diseases. Jim West, CEO of Clara Biotech, joins us to share his perspective on research and innovation using exosomes as well as life in a biotech startup. He provides great insights into where this technology is today, the challenges being experienced in the field, and the potential and opportunity that the field of applied exosome research represents in the future.
Tune in today. Subscribe to get future episodes. Share with a friend or colleague that might enjoy too!
Visit https://thermofisher.com/molbioschool to access molecular biology resources and educational content.
Experience the Speaking of Mol Bio podcast in its extended video format for a more immersive journey, while also ensuring accessibility with downloadable transcripts for each episode.
Watch now at thermofisher.com/podcast-video